1. Resveratrol provides benefits in mice with type II diabetes‑induced chronic renal failure through AMPK signaling pathway
   Haiyan Guo et al, 2018, Experimental and Therapeutic Medicine CrossRef
2. Advances in the study of emodin: an update on pharmacological properties and mechanistic basis
   Qi Zheng et al, 2021, Chinese Medicine CrossRef
3. Inhibition of Renal Tubular Epithelial Mesenchymal Transition and Endoplasmic Reticulum Stress-Induced Apoptosis with Shenkang Injection Attenuates Diabetic Tubulopathy
   Wen-Wen Wang et al, 2021, Frontiers in Pharmacology CrossRef
4. The progress and prospect of natural components in rhubarb (Rheum ribes L.) in the treatment of renal fibrosis
   Yangyang Wang et al, 2022, Frontiers in Pharmacology CrossRef
5. Shenkang Injection and Its Three Anthraquinones Ameliorates Renal Fibrosis by Simultaneous Targeting IƙB/NF-ƙB and Keap1/Nrf2 Signaling Pathways
   Liang-Pu Luo et al, 2021, Frontiers in Pharmacology CrossRef
6. Shenkang protects renal function in diabetic rats by preserving nephrin expression
   Zhihui Qu et al, 2023, BMC Complementary Medicine and Therapies CrossRef
7. A novel liquid chromatography Orbitrap mass spectrometry method with full scan for simultaneous determination of multiple bioactive constituents of Shenkang injection in rat tissues: Application to tissue distribution and pharmacokinetic studies
   Jie Yang et al, 2018, Biomedical Chromatography CrossRef
8. Chinese Herbal Injections for Primary Nephrotic Syndrome in Adults: A Systematic Review and Network Meta-Analysis
   Shisheng Han et al, 2020, Evidence-Based Complementary and Alternative Medicine CrossRef
9. ShenKang Injection Attenuates Renal Fibrosis by Inhibiting EMT and Regulating the Wnt/β-Catenin Pathway
   Hui-Ting Wei et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
10. Network pharmacology-based study on the mechanism of ShenKang injection in diabetic kidney disease through Keap1/Nrf2/Ho-1 signaling pathway
    Yunhua Liu et al, 2023, Phytomedicine CrossRef
11. The nuclear factor kappa B signaling pathway is a master regulator of renal fibrosis
    Na Ren et al, 2024, Frontiers in Pharmacology CrossRef
12. Shen-Kang protects against tacrolimus-induced renal injury
    Long Ye Zhang et al, 2019, The Korean Journal of Internal Medicine CrossRef
13. Efficacy and safety of Shenkang injection in the treatment of chronic renal failure
    JuXiang Mei et al, 2021, Medicine CrossRef